California Public Employees Retirement System Ardelyx, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.55 - $8.98 $973,330 - $1.33 Million	-148,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$6.1 - $7.69 $84,143 - $106,075	-13,794 Reduced 8.49%	148,600 $984,000
Q4 2020 Feb 02, 2021	SELL	$5.05 - $7.1 $15,655 - $22,010	-3,100 Reduced 1.87%	162,394 $1.05 Million
Q3 2020 Nov 05, 2020	BUY	$5.25 - $7.08 $1,449 - $1,954	276 Added 0.17%	165,494 $869,000
Q2 2020 Aug 12, 2020	BUY	$5.37 - $8.11 $311,078 - $469,804	57,929 Added 53.99%	165,218 $1.14 Million
Q1 2020 May 12, 2020	BUY	$4.35 - $8.79 $96,569 - $195,137	22,200 Added 26.09%	107,289 $610,000
Q4 2019 Jan 27, 2020	BUY	$4.23 - $8.29 $359,926 - $705,387	85,089 New	85,089 $639,000

Others Institutions Holding ARDX

# of Institutions

218

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account